By Joe Gough, Solutions Specialist for Academic Medical Centers and Universities
COVID-19 has had a dramatic impact on US clinical care, including how sites have worked to maintain research operations throughout the pandemic. According to the American Hospital Association, the financial impact of COVID-19 on the US healthcare system is estimated to total $325 billion in lost revenue in 2020 and the related negative impact has put downstream pressure on clinical research activities.
Our team at Greenphire recently conducted a webinar, The Impact of COVID-19 on Research Sites: Planning for the Road Back to Full Trial Operations.
The financial and logistical challenges faced by our site partners have been substantial, but I’m pleased to recap in this blog the adaptations they’ve made to manage through the current environment.